HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Industrial Cannabis/Industrial Hemp

434.995

-10.765-2.41%

Number of Gainers:2

Number of Losers:3

Number of Flat:2

PE:- -

High:445.760

Open:445.760

Low:429.847

Close:445.760

Volume:87.53M

Turnover:83.86M

Market Cap:17.80B

Float Cap:17.80B

Loading ...

LIFETECH SCI's LantvalTM Aortic Valve Replacement System Clears NMPA Fast-Track Review for Innovative Devices

Evergreen Products H1 FY26 Profit Rises 30.4% to Hk$24.6 Million; Revenue Climbs 24.2% to Hk$578.2 Million

EVERGREEN PG Chairman and CEO Increases Stake with 60,000-Share Purchase at HKD 0.485 Each

Sihuan Pharma Affiliate Xuanzhu Biopharm Grants Innobic Exclusive Thailand Commercialization Rights for Bireociclib Tablets

EVERGREEN PG Cancels 6.756 Million Repurchased Shares on September 2

Sihuan Pharma Grants 116,150,000 Share Awards Under 2026 Incentive Scheme at HK$ 0.74 Each

Meilleure Health (SEHK:2327) Stock Price Lags Fresh Profit Surge

Simply Wall St.

LifeTech Swings to FY26 H1 Net Loss of RMB 34.3 Million; Revenue Falls 11.2% to RMB 600.8 Million

Sihuan Pharmaceutical (SEHK:460) Stock Price Lags Profit Recovery as Valuation Stretches

Simply Wall St.

Meilleure Health International Reports 87% Surge in Interim Profit to HK$28.34 Million

Hong Kong's Meilleure Health H1 Revenue Surges on Property Sales, but Margins Hit

Meilleure Health Declares Interim Dividend of HKD 0.0015 a Share

Meilleure Health FY26 H1 Profit Rises 87.4% to HK$ 28.33 Million; Revenue Climbs 840.6% to HK$ 164.57 Million

Meilleure Health International Industry Group Declared an Interim Dividend of Hk0.15 Cents Per Share

THOMSON REUTERS

Meilleure Health International Industry Group H1 Net Income Attributable HKD 28.3 Million

THOMSON REUTERS

Sihuan Pharma Files HKEX Next-Day Return Disclosing Share Repurchase at HKD 0.81

Grand Pharmaceutical H1 Revenue Rises on Nuclear Medicine Demand

China's Zhongzhi Pharmaceutical H1 Revenue Falls 10%

Sihuan Pharma FY26 H1 Profit Attributable to Owners Rises 119% to RMB 224.7 Million; Revenue Increases 1.3% to RMB 1.16 Billion

Sihuan Pharmaceutical Files Board, Committee Roles and Disclosure-Responsible Management List

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/BK1600/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1600","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1600\",,,,,undefined,":{"symbol":"BK1600","market":"HK","secType":"PLATE","nameCN":"Industrial Cannabis/Industrial Hemp","latestPrice":434.99512,"timestamp":1789027721934,"preClose":445.7604,"halted":0,"volume":87533000,"delay":0,"changeRate":-0.02415,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-10.765289,"latestTime":"09-10 16:00:00","open":445.7604,"high":445.7604,"low":429.847,"amount":83864691,"amplitude":0.035699,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789090200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789003800000,1789012800000],[1789016400000,1789027200000]],"pbRate":1.302258,"peRate":33.132166,"turnoverRate":0.002896,"increases":2,"decrements":3,"flats":2,"marketCap":17797255472,"floatMarketCap":17797255472},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1600\",,,,,undefined,":{"symbol":"BK1600","high":445.7604,"amplitude":0.035699,"preClose":445.7604,"low":429.847,"pbRate":"1.302258","latestPrice":434.99512,"volume":87533000,"delay":0,"open":445.7604,"prevYearClose":572.4504,"prevWeekClose":455.168,"prevMonthClose":440.955,"prevQuarterClose":454.412,"fiveDayClose":446.633,"twentyDayClose":470.79,"sixtyDayClose":470.474,"secType":"PLATE","market":"HK","turnoverRate":0.002896,"peRate":33.132166,"marketCap":17797255472,"floatMarketCap":17797255472,"timestamp":1789027721934,"nameCN":"Industrial Cannabis/Industrial Hemp"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1600\",,,,undefined,":{"bkCode":"BK1600","up":2,"down":3,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1600\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1156894230","title":"LIFETECH SCI's LantvalTM Aortic Valve Replacement System Clears NMPA Fast-Track Review for Innovative Devices","url":"https://stock-news.laohu8.com/highlight/detail?id=1156894230","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156894230?lang=en_us&edition=fundamental","pubTime":"2026-09-10 08:08","pubTimestamp":1788998900,"startTime":"0","endTime":"0","summary":"LIFETECH SCI (01302) has announced that it received an official written notice from the National Medical Products Administration (NMPA) on September 9, 2026, confirming that the LantvalTM aortic...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01302","BK1600","BK1583","LGHT","BK1100","159883","GDOC","MDEV","PTH","HART","LNGR","IEIH","MEDX","RSPH","AGNG","BK1574","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665832526","title":"Evergreen Products H1 FY26 Profit Rises 30.4% to Hk$24.6 Million; Revenue Climbs 24.2% to Hk$578.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2665832526","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665832526?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:51","pubTimestamp":1788857469,"startTime":"0","endTime":"0","summary":"Evergreen Products H1 FY26 profit rises 30.4% to HK$24.6 million; revenue climbs 24.2% to HK$578.2 millionEvergreen Products Group posted profit of HK$24.55 million, up 30.4%, as revenue climbed 24.2%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDLj1JSt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0920840948.USD","LU1105468828.SGD","IE0034235071.USD","LU2449936058.SGD","BK5152","LU0171281750.USD","LU0345776255.USD","LU1170363599.USD","LU1242518857.USD","LU0106831901.USD","LU0149534421.HKD","LU0348816934.USD","LU2293690249.USD","LU0264606111.USD","LU1267930490.SGD","LU0857590862.USD","LU1668664300.SGD","LU1242518931.SGD","LU0164880469.USD","01962","LU2114397693.USD","IE0008369823.USD","LU0516422366.SGD","LU0607220059.USD","LU0572939691.SGD","LU1098665638.USD","LU0918141705.HKD","BK1600","LU0516422952.EUR","LU0417516738.SGD","HSBA.UK","LU0918141887.USD","LU1023061473.USD","BK1585","LU0307460666.USD","LU0964806797.USD","LU1481107354.HKD","LU1770036033.HKD","LU0109981661.USD","LU1023061713.HKD","LU0171293334.USD","LU1003076772.USD","LU0634319403.HKD","LU0831103253.SGD","LU0588546209.SGD","LU0572940350.SGD","LU0215105999.USD","LU0898667661.SGD","LU1046234339.USD","LU1153584641.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143874124","title":"EVERGREEN PG Chairman and CEO Increases Stake with 60,000-Share Purchase at HKD 0.485 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=1143874124","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143874124?lang=en_us&edition=fundamental","pubTime":"2026-09-07 08:10","pubTimestamp":1788739846,"startTime":"0","endTime":"0","summary":"Hong Kong Stock Exchange filings reveal that on September 3, Chairman and Chief Executive Officer Zhang Youcang boosted his holdings in EVERGREEN PG by acquiring 60,000 shares at a price of HKD 0.485...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EWH","BK1585","01962","BK1600","BK1207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664878574","title":"Sihuan Pharma Affiliate Xuanzhu Biopharm Grants Innobic Exclusive Thailand Commercialization Rights for Bireociclib Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=2664878574","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664878574?lang=en_us&edition=fundamental","pubTime":"2026-09-03 17:18","pubTimestamp":1788427127,"startTime":"0","endTime":"0","summary":"Sihuan Pharma affiliate Xuanzhu Biopharm grants Innobic exclusive Thailand commercialization rights for Bireociclib tabletsSihuan Pharmaceutical’s non-wholly owned unit Xuanzhu Biopharm granted exclus","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL8K9jwT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1593","BK1600","00460","BK1515","02575"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104574280","title":"EVERGREEN PG Cancels 6.756 Million Repurchased Shares on September 2","url":"https://stock-news.laohu8.com/highlight/detail?id=1104574280","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104574280?lang=en_us&edition=fundamental","pubTime":"2026-09-02 16:42","pubTimestamp":1788338541,"startTime":"0","endTime":"0","summary":"EVERGREEN PG (01962) announced that on September 2, 2026, it canceled 6.756 million shares that had been previously repurchased.The cancellation of these shares reduces the company's total issued share capital accordingly.This move aligns with the company's ongoing capital management strategy.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1207","01962","BK1585","BK1600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664851528","title":"Sihuan Pharma Grants 116,150,000 Share Awards Under 2026 Incentive Scheme at HK$ 0.74 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2664851528","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664851528?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:58","pubTimestamp":1788267535,"startTime":"0","endTime":"0","summary":"Sihuan Pharma grants 116,150,000 share awards under 2026 incentive scheme at HK$ 0.74 eachSihuan Pharmaceutical launched a 2026 share award grant covering 116,150,000 shares, about 1.27% of issued sha","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL9s25cf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1593","BK1600","BK1191","00460"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662093518","title":"Meilleure Health (SEHK:2327) Stock Price Lags Fresh Profit Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=2662093518","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662093518?lang=en_us&edition=fundamental","pubTime":"2026-08-28 20:31","pubTimestamp":1787920272,"startTime":"0","endTime":"0","summary":"Meilleure Health International Industry Group stock closed at HK$0.24, with recent returns over the past week and month slightly in the red and the 90 day move deeper in decline. Yet H1 2026 earnings landed with a headline that is hard to ignore. Revenue for the period came in at HK$164.57m and net income reached HK$28.34m, which feeds into a trailing 12 month profit profile that investors may wish to weigh carefully in light of the recent share price weakness.\nLove the fresh profit profile...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/3081000-choice2-main-header/1585186749644","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3081000-choice2-main-header/1585186749644"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/capital-goods/hkg-2327/meilleure-health-international-industry-group-shares/news/meilleure-health-sehk2327-stock-price-lags-fresh-profit-surg","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/capital-goods/hkg-2327/meilleure-health-international-industry-group-shares/news/meilleure-health-sehk2327-stock-price-lags-fresh-profit-surg","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1124","BK1600","02327"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662055928","title":"LifeTech Swings to FY26 H1 Net Loss of RMB 34.3 Million; Revenue Falls 11.2% to RMB 600.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662055928","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662055928?lang=en_us&edition=fundamental","pubTime":"2026-08-28 12:20","pubTimestamp":1787890843,"startTime":"0","endTime":"0","summary":"LifeTech swings to FY26 H1 net loss of RMB 34.3 million; revenue falls 11.2% to RMB 600.8 millionLifeTech Scientific posted a net loss attributable to owners of RMB 34.3 million, swinging from profit;","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDLdQ5JC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","01302","BK1600","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662084715","title":"Sihuan Pharmaceutical (SEHK:460) Stock Price Lags Profit Recovery as Valuation Stretches","url":"https://stock-news.laohu8.com/highlight/detail?id=2662084715","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662084715?lang=en_us&edition=fundamental","pubTime":"2026-08-27 22:24","pubTimestamp":1787840647,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical Holdings Group entered these results following a period of weak share price performance, with the stock down over the past week, month and quarter, yet trading on a rich P/E of 21x. That is a set up for emotional trading. The headline from this half year is simple. Profitability has firmed up, with basic earnings per share at C¥0.0249 on revenue of C¥1,161.2m. The tug of war now is between investors who are concerned about the valuation strain and those who see a company...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-460/sihuan-pharmaceutical-holdings-group-shares/news/sihuan-pharmaceutical-sehk460-stock-price-lags-profit-recove","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-460/sihuan-pharmaceutical-holdings-group-shares/news/sihuan-pharmaceutical-sehk460-stock-price-lags-profit-recove","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1515","00460","BK1600","BK1191","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173617335","title":"Meilleure Health International Reports 87% Surge in Interim Profit to HK$28.34 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1173617335","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173617335?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:47","pubTimestamp":1787827638,"startTime":"0","endTime":"0","summary":"Meilleure Health International (02327) has announced its interim results for 2026, posting a revenue of approximately HK$165 million, marking a substantial year-on-year increase of about 840.6%.The...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1124","02327","BK1600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662706948","title":"Hong Kong's Meilleure Health H1 Revenue Surges on Property Sales, but Margins Hit","url":"https://stock-news.laohu8.com/highlight/detail?id=2662706948","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662706948?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:44","pubTimestamp":1787827454,"startTime":"0","endTime":"0","summary":"Hong Kong's Meilleure Health H1 revenue surges on property sales, but margins hitOverviewHong Kong healthcare and property group's H1 revenue rose 841% yr/yr, driven by property salesGross profit marg","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL1N44O0FX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02327","00373","BK1600","BK1188","BK1124"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662632706","title":"Meilleure Health Declares Interim Dividend of HKD 0.0015 a Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2662632706","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662632706?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:43","pubTimestamp":1787827424,"startTime":"0","endTime":"0","summary":"Meilleure Health declares interim dividend of HKD 0.0015 a shareMeilleure Health declared an interim dividend of HKD 0.0015 per share for the six months ended June 30, 2026.Shares trade ex-dividend on Sept. 9.Holders on record as of Sept. 16 will be entitled to the payout.Payment is scheduled for Sept. 30.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Meilleure Health International Industry Group Limited published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on August 27, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL20r5PB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1600","02327","BK1124"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662050827","title":"Meilleure Health FY26 H1 Profit Rises 87.4% to HK$ 28.33 Million; Revenue Climbs 840.6% to HK$ 164.57 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662050827","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662050827?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:35","pubTimestamp":1787826924,"startTime":"0","endTime":"0","summary":"Meilleure Health FY26 H1 profit rises 87.4% to HK$ 28.33 million; revenue climbs 840.6% to HK$ 164.57 millionMeilleure Health posted profit attributable to owners of HK$28.34 million, up 87.4%, with E","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL6srS50:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02327","BK1124","BK1600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662705708","title":"Meilleure Health International Industry Group Declared an Interim Dividend of Hk0.15 Cents Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2662705708","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662705708?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:34","pubTimestamp":1787826884,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nPLXGKTSGX:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1124","BK1600","02327"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662270548","title":"Meilleure Health International Industry Group H1 Net Income Attributable HKD 28.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662270548","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662270548?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:34","pubTimestamp":1787826884,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nPLXGKTSGX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02327","BK1124","BK1600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662705289","title":"Sihuan Pharma Files HKEX Next-Day Return Disclosing Share Repurchase at HKD 0.81","url":"https://stock-news.laohu8.com/highlight/detail?id=2662705289","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662705289?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:34","pubTimestamp":1787826855,"startTime":"0","endTime":"0","summary":"Sihuan Pharma files HKEX next-day return disclosing share repurchase at HKD 0.81Sihuan Pharmaceutical repurchased 10,000,000 ordinary shares on Aug. 27, holding all as treasury shares.Buyback price ra","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL6cXYkS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","BK1191","BK1515","00460","BK1600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662717592","title":"Grand Pharmaceutical H1 Revenue Rises on Nuclear Medicine Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2662717592","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662717592?lang=en_us&edition=fundamental","pubTime":"2026-08-26 21:54","pubTimestamp":1787752465,"startTime":"0","endTime":"0","summary":"Grand Pharmaceutical H1 revenue rises on nuclear medicine demandOverviewHong Kong-listed pharma group's H1 revenue rose 3.2% yr/yr to HK$6.39 blnNet income attributable to owners fell to HK$1.06 bln f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL1N44N0MX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","03692","BK1589","00512","BK1600","00460","BK1515","BK1191","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662715194","title":"China's Zhongzhi Pharmaceutical H1 Revenue Falls 10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662715194","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662715194?lang=en_us&edition=fundamental","pubTime":"2026-08-26 19:36","pubTimestamp":1787744170,"startTime":"0","endTime":"0","summary":"China's Zhongzhi Pharmaceutical H1 revenue falls 10%OverviewChina pharmaceutical maker's half-year revenue fell 10.3% yr/yrProfit attributable to owners rose 3.8% yr/yrGross profit and margin declined","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL1N44N0G0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1589","00460","BK1600","BK1606","BK1191","BK1515","03737","BK1593","01681","03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662973617","title":"Sihuan Pharma FY26 H1 Profit Attributable to Owners Rises 119% to RMB 224.7 Million; Revenue Increases 1.3% to RMB 1.16 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2662973617","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662973617?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:08","pubTimestamp":1787738933,"startTime":"0","endTime":"0","summary":"Sihuan Pharma FY26 H1 profit attributable to owners rises 119% to RMB 224.7 million; revenue increases 1.3% to RMB 1.16 billionSihuan Pharmaceutical posted profit attributable to owners of RMB 224.7 m","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDLc1wDYT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","00460","BK1600","BK1593","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662794653","title":"Sihuan Pharmaceutical Files Board, Committee Roles and Disclosure-Responsible Management List","url":"https://stock-news.laohu8.com/highlight/detail?id=2662794653","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662794653?lang=en_us&edition=fundamental","pubTime":"2026-08-26 17:38","pubTimestamp":1787737093,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical files board, committee roles and disclosure-responsible management listSihuan Pharmaceutical named Che Fengsheng as chairman; Guo Weicheng as vice chairman, chief executive; exec","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL1yGHl8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1600","BK1191","BK1593","BK1515","00460"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":26,"code":"91000000","status":"200"}]}}